---
$id: https://graph.org.ai/products/commodity/51343809
$type: Product
source: UNSPSC
code: "51343809"
title: "Dolutegravir/lamivudine/tenofovir DF"
class: "51343800"
classTitle: "Combination antivirals"
family: "51340000"
familyTitle: "Antiviral drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dolutegravir/lamivudine/tenofovir DF

**UNSPSC Code**: 51343809
**Class**: [Combination antivirals](Combination antivirals.mdx)
**Family**: [Antiviral drugs](../Antiviral drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a combination drug for treatment of HIV. The first component, DOLUTEGRAVIR, has US FDA Unique Ingredient Identifier of DKO1W9H7M1. The second component, LAMIVUDINE, has US FDA Unique Ingredient Identifier of 2T8Q726O95. The third component, TENOFOVIR DISOPROXIL FUMARATE, has US FDA Unique Ingredient Identifier of OTT9J7900I.

